Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 40: 11-13, 1994;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kataoka, S.
Right arrow Articles by Howard, B. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kataoka, S.
Right arrow Articles by Howard, B. V.

Clinical Chemistry, Vol 40, 11-13, Copyright © 1994 by American Association for Clinical Chemistry

Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype

S Kataoka, M Paidi and BV Howard
Medlantic Research Institute, Washington, DC 20010-2933.

We developed a rapid, accurate method for phenotyping apoprotein E that can be used for large-scale population studies. In this method, adapted from the method of Kamboh et al. (J Lipid Res 1988;29:1535-43), 10- microL plasma samples are incubated with dithiothreitol and Tween-20 for 15 min and then applied to 5% polyacrylamide gels containing ampholyte (pH 4.5-8) and urea (3 mol/L). After 2 h of isoelectric focusing, the apoprotein E bands are made visible by immunoblotting. Utilizing whole plasma, this method does not require time-consuming ultracentrifugation, delipidation of samples, or dialysis. Small amounts of plasma are required, electrofocusing time is short, and as many as 160 samples can be processed per day. Identification of phenotype is easily accomplished by noting the location and number of protein bands instead of their intensity. Because identification of phenotype is not affected by sialylation, neuraminidase treatment is not necessary. Agreement in identification of 301 individuals from blinded duplicates was 96%, and there was 98% concordance of results for 431 samples that had undergone genetic typing. This method is thus well suited for large-scale population studies.


The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Clin BiochemHome page
E. Wardaningsih, T. Miida, U. Seino, Y. Fueki, M. Ito, K. Nagasaki, T. Kikuchi, M. Uchiyama, S. Hirayama, O. Hanyu, et al.
Low adiponectin state is associated with metabolic abnormalities in obese children, particularly depending on apolipoprotein E phenotype
Ann Clin Biochem, September 1, 2008; 45(5): 496 - 503.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
K. E. North, H. H. H. Goring, S. A. Cole, V. P. Diego, L. Almasy, S. Laston, T. Cantu, B. V. Howard, E. T. Lee, L. G. Best, et al.
Linkage analysis of LDL cholesterol in American Indian populations: the Strong Heart Family Study
J. Lipid Res., January 1, 2006; 47(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. W.P.F. Kardaun, L. White, H. E. Resnick, H. Petrovitch, S. M. Marcovina, A. M. Saunders, D. J. Foley, and R. J. Havlik
Genotypes and Phenotypes for Apolipoprotein E and Alzheimer Disease in the Honolulu-Asia Aging Study
Clin. Chem., October 1, 2000; 46(10): 1548 - 1554.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. MIYATA, S. SUGIYAMA, M. NANGAKU, D. SUZUKI, K.-I. URAGAMI, R. INAGI, H. SAKAI, and K. KUROKAWA
Apolipoprotein E2/E5 Variants in Lipoprotein Glomerulopathy Recurred in Transplanted Kidney
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1590 - 1595.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. S. Gray, D. C. Robbins, W. Wang, J. L. Yeh, R. R. Fabsitz, L. D. Cowan, T. K. Welty, E. T. Lee, R. M. Krauss, and B. V. Howard
Relation of LDL Size to the Insulin Resistance Syndrome and Coronary Heart Disease in American Indians : The Strong Heart Study
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2713 - 2720.
[Abstract] [Full Text]

Home page
 StrokeHome page
J. G. Terry, G. Howard, M. Mercuri, M. G. Bond, and J. R. Crouse III
Apolipoprotein E Polymorphism Is Associated With Segment-Specific Extracranial Carotid Artery Intima-Media Thickening
Stroke, October 1, 1996; 27(10): 1755 - 1759.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Haffner, M. P. Stern, H. Miettinen, D. Robbins, and B. V. Howard
Apolipoprotein E Polymorphism and LDL Size in a Biethnic Population
Arterioscler Thromb Vasc Biol, September 1, 1996; 16(9): 1184 - 1188.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Kataoka, D. C. Robbins, L. D. Cowan, O. Go, J. L. Yeh, R. B. Devereux, R. R. Fabsitz, E. T. Lee, T. K. Welty, and B. V. Howard
Apolipoprotein E Polymorphism in American Indians and Its Relation to Plasma Lipoproteins and Diabetes: The Strong Heart Study
Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 918 - 925.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Association for Clinical Chemistry.